000627 Hubei Biocause Pharmaceutical

Watchlist

Not Open Jan 10 15:00 CST

17.49BMarket Cap-22.69P/E (TTM)

Hubei Biocause Pharmaceutical Key Stats

Revenue

EPS

EBIT

No Data

Tianmao Group: Report for the third quarter of 2024

Oct 30, 2024 12:00 ET

Tianmao Group: Tianmao Group\'s performance forecast for the first three quarters of 2024

Oct 14, 2024 12:00 ET

Tianmao Group: Guohua Life 2024 Semi-Annual Report

Aug 30, 2024 12:00 ET

Tianmao Group: 2024 Semi-Annual Report

Aug 30, 2024 12:00 ET

Overall

No Data